Financing Cash Flow
Gilead Sciences Financing Cash Flow decreased by 235.6% to -$4.24B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 23.7%, from -$3.43B to -$4.24B. Over 3 years (FY 2021 to FY 2025), Financing Cash Flow shows an upward trend with a -4.4% CAGR.
Analysis
How to read this metric
A large negative value typically indicates a company is returning capital to shareholders or paying down debt, while a positive value suggests the company is raising external capital to fund operations or acquisitions.
Detailed definition
This metric represents the net flow of cash between a company and its capital providers, including shareholders and lend...
Peer comparison
Large-cap peers like Microsoft or Alphabet similarly show large negative financing outflows due to aggressive share repurchase programs and dividend distributions.
net_cash_from_financingHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$931.00M | -$3.53B | -$1.94B | -$1.79B | -$1.00B | -$2.12B | -$1.55B | -$1.41B | -$1.10B | -$1.52B | -$1.10B | -$1.36B | -$2.95B | -$1.38B | -$3.43B | -$1.57B | -$1.49B | -$1.26B | -$4.24B |
| QoQ Change | — | -278.8% | +44.9% | +7.6% | +44.1% | -111.2% | +26.6% | +9.5% | +21.7% | -38.0% | +27.6% | -23.8% | -117.0% | +53.3% | -148.4% | +54.3% | +5.0% | +15.2% | -235.6% |
| YoY Change | — | — | — | — | -7.7% | +39.9% | +20.0% | +21.6% | -9.8% | +28.3% | +29.3% | +3.2% | -168.2% | +9.2% | -151.7% | +46.9% | -8.0% | — | -23.7% |
Financing Cash Flow at Other Companies
Frequently Asked Questions
- What is Gilead Sciences's financing cash flow?
- Gilead Sciences (GILD) reported financing cash flow of -$4.24B in Q1 2026.
- How has Gilead Sciences's financing cash flow changed year-over-year?
- Gilead Sciences's financing cash flow decreased by 23.7% year-over-year, from -$3.43B to -$4.24B.
- What is the long-term trend for Gilead Sciences's financing cash flow?
- Over 3 years (2021 to 2025), Gilead Sciences's financing cash flow has grown at a -4.4% compound annual growth rate (CAGR), from -$8.88B to -$7.75B.
- What does financing cash flow mean?
- The total amount of money a company spends or receives from borrowing debt and managing its own shares and dividends.